Loading insider details...
Beta
Latest Form 4 (Jul 24, 2026): Sale of 8,111 NTLA shares, $91.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 24, 2026 | Intellia Therapeutics, Inc. (NTLA) | Sale | 8,111 | $91.2K |
| Jul 6, 2026 | Intellia Therapeutics, Inc. (NTLA) | Sale | 4,677 | $84.2K |
| Mar 3, 2026 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 61,280 | n/a |
| Jan 7, 2026 | Intellia Therapeutics, Inc. (NTLA) | Sale | 6,379 | $58.8K |
| Jul 25, 2025 | Intellia Therapeutics, Inc. (NTLA) | Sale | 7,462 | $104.6K |
| Mar 4, 2025 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 47,200 | n/a |
| Jul 24, 2024 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 66,324 | n/a |
| Mar 5, 2024 | FATE THERAPEUTICS INC (FATE) | Sale | 2,447 | $19.0K |
| Feb 2, 2024 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 425,000 | n/a |
| Jan 30, 2024 | FATE THERAPEUTICS INC (FATE) | Sale | 1,849 | $9.2K |